Acute and chronic effects of opioids on δ and μ receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes

Journal of Neurochemistry

Volumn 68, Issue 4, 1997, Pages 1462-1472

  Breivogel, Christopher S ^a   Selley, Dana E ^a   Childers, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Desensitization; G protein; Guanosine 5' O(3 35S thio) triphosphate; Opioid; Receptor; Receptor

Indexed keywords

DELTA OPIATE RECEPTOR; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MU OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; DRUG RECEPTOR BINDING; LONG TERM EXPOSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION;

ANIMALIA;

EID: 0031000795     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.68041462.x     Document Type: Article

References (48)

1. Asano T., Pedersen S. E., Scott C. W., and Ross E. M. (1984) Reconstitution of catecholamine-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to the stimulatory GTP-binding protein of adenylate cyclase. Biochemistry 23, 5460-5467.
2. Bradford M. M. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
3. Carter B. D. and Medzihradsky F. (1993) Receptor mechanisms of opioid tolerance in SH-SY5Y human neural cells. Mol. Pharmacol. 43, 465-473.
4. Chang K.-J. and Cuatrecasas P. (1979) Multiple opiate receptors: enkephalins and morphine bind to receptors of different specificity. J. Biol. Chem. 254, 2610-2618.
5. Chang K.-J., Eckel R. W., and Blanchard S. G. (1982) Opioid peptides induce reduction of enkephalin receptors in cultured neuroblastoma cells. Nature 296, 446-448.
6. Chen Y., Mestek A., Liu J., Hurley J. A., and Yu L. (1993) Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
7. Childers S. R. (1991) Opioid receptor-coupled second messengers. Life Sci. 48, 1991-2003.
8. 125I-β-endorphin opioid receptor sites in NG108-15, but not SK-N-SH neuroblastoma cells. Life Sci. 49, PL147-PL152.
9. Corbett A. D., Gillan M. G. C., Kosterlitz H. W., and Paterson S. J. (1985) Binding and pharmacological profile of a highly selective ligand for the κ-opioid receptor - U-69,593. Br. J. Pharmacol. 86, 704P.
10. Corbett A. D., Paterson S. J., and Kosterlitz H. W. (1993) Selectivity of ligands for opioid receptors, in Opioids I (Herz A., ed), pp. 645-679. Springer-Verlag, Berlin.
11. Costa T., Klinz F.-J., Vachon L., and Herz A. (1988) Opioid receptors are coupled tightly to G proteins but loosely to adenylate cyclase in NG108-15 cell membranes. Mol. Pharmacol. 34, 744-754.
12. Emmerson P. J., Clark M. J., Mansour A., Akil H., Woods J. H., and Medzihradsky F. (1996) Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the μ opioid receptor. J. Pharmacol. Exp. Ther. 278, 1121-1127.
13. Evans C. J., Keith D. E. Jr., Morrison H., Magendzo K., and Edwards R. H. (1992) Cloning of a delta opioid receptor by functional expression. Science 258, 1952-1955.
14. o in reconstituted phospholipid vesicles. J. Biol. Chem. 264, 3909-3915.
15. Gierschik P., Moghtader R., Straub C., Dieterich K., and Jakobs K. H. (1991) Signal amplification in HL-60 granulocytes: evidence that the chemotactic peptide receptor catalytically activates guanine nucleotide proteins in native plasma membranes. Eur. J. Biochem. 197, 725-732.
16. Hilf G., Gierschik P., and Jakobs K. H. (1989) Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. Eur. J. Biochem. 186, 725-731.
17. Hilf G., Kupprion C., Wieland T., and Jakobs K. H. (1992) Dissociation of guanosine 5′-[γ-thio]triphosphate from guanine-nucleotide-binding regulatory proteins in native cardiac membranes: regulation by nucleotides and muscarinic acetylcholine receptors. Eur. J. Biochem. 204, 725-731.
18. Hutchinson M., Kosterlitz H. W., Leslie F. M., Waterfield A. A., and Terenius L. (1975) Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Br. J. Pharmacol. 55, 541-546.
19. Kenakin T. (1993) Efficacy, in Pharmacologic Analysis of Drug-Receptor Interaction (Kenakin T., ed), pp. 249-277. Raven Press, New York.
20. Kieffer B. L., Befort K., Gaveriaux-Ruff C., and Hirth C. G. (1992) The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89, 12048-12052.
21. Law P. Y., Hom D. S., and Loh H. H. (1982) Loss of opiate receptor activity in neuroblastoma × glioma NG108-15 hybrid cells after chronic opiate treatment. Mol. Pharmacol. 22, 1-4.
22. Law P. Y., Hom D. S., and Loh H. H. (1983) Opiate receptor down-regulation and desensitization in neuroblastoma × glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol. Pharmacol. 24, 413-424.
23. Law P.-Y., Hom D. S., and Loh H. L. (1984) Down-regulation of opiate receptor in neuroblastoma × glioma NG108-15 hybrid cells: chloroquine promotes accumulation of tritiated enkephalin in the lysosomes. J. Biol. Chem. 259, 4096-4104.
24. Law P. Y., Louie A. K., and Loh H. H. (1985) Effect of pertussis toxin treatment on the down-regulation of opiate receptors in neuroblastoma × glioma NG108-15 hybrid cells. J. Biol. Chem. 260, 14818-14823.
25. Law P. Y., Hom D. S., and Loh H. H. (1991) Effects of chronic D-Ala2, D-Leu5-enkephalin or pertussis toxin treatment on the high-affinity state of delta opioid receptor in neuroblastoma × glioma NG108-15 hybrid cells. J. Pharmacol. Exp. Ther. 256, 710-716.
26. Lazareno S., Farries T., and Birdsall N. J. M. (1993) Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors M1-M4. Life Sci. 52, 449-456.
27. 35S]thio)triphosphate binding. Mol. Pharmacol. 44, 115-123.
28. Moses M. A. and Snell C. R. (1984) The regulation of δ-opiate receptor density on 108CC15 neuroblastoma × glioma hybrid cells. Br. J. Pharmacol. 81, 169-174.
29. Munson P. J. and Rodbard D. (1980) LIGAND: a versatile approach for characterization of ligand-binding systems. Anal. Biochem. 107, 220-239.
30. Polastron J., Jauzac P., and Meunier J.-C. (1992) The δ-opioid receptor in neuroblastoma × glioma NG108-15 hybrid cells is strongly precoupled to a G-protein. Eur. J. Pharmacol. 226, 133-139.
31. Portoghese P. S., Sultana M., and Takemori A. E. (1988) Naltrindole, a highly selective and potent non-peptide δ-opioid receptor antagonist. Eur. J. Pharmacol. 146, 185-186.
32. Premont R. T., Inglese J., and Lefkowitz R. J. (1995) Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9, 175-182.
33. Puttfarcken P. S. and Cox B. M. (1989) Morphine-induced desensitization and downregulation at mu-receptors in 7315C pituitary tumor cells. Life Sci. 45, 1937-1942.
34. 125I]β-endorphin binding to NG108-15 and SK-N-SH cell membranes: specific cation requirements. Brain Res. 493, 23-32.
35. 2 GTPase studies. J. Pharmacol. Exp. Ther. 263, 99-104.
36. 35S]GTP-γS binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Mol. Pharmacol. (in press).
37. Sharma S. K., Klee W. A., and Nirenberg M. (1975) Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA 72, 3092-3096.
38. 35S]thio]triphosphate binding. Proc. Natl. Acad. Sci. USA 92, 7242-7246.
39. Sim L. J., Selley D. E., Xiao R., and Childers S. R. (1996) Differences in G-protein activation by mu and delta opioid, and cannabinoid, receptors in rat striatum. Eur. J. Pharmacol. 307, 95-107.
40. Takemori A. E., Begonia Y. H., Naeseth J. S., and Portoghese P. S. (1988) Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesia and receptor binding assays. J. Pharmacol. Exp. Ther. 246, 255-258.
41. Thompson R. C., Mansour A., Akil H., and Watson S. J. (1993) Cloning and pharmacological characterization of a rat μ opioid receptor. Neuron 11, 903-913.
42. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol. 47, 848-854.
43. Vachon L., Costa T., and Herz A. (1987a) GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells. Mol. Pharmacol. 31, 159-168.
44. Vachon L., Costa T., and Herz A. (1987b) Opioid receptor desensitization in NG108-15 cells differential effects of a full and a partial agonist on the opioid-dependent GTPase. Biochem. Pharmacol. 36, 2889-2897.
45. Wang J.-B., Johnson P. S., Persico A. M., Hawkins A. L., Griffin C. A., and Uhl G. R. (1994) Human μ opiate receptor: cDNA and genomic clones, pharmacological characterization and chromosomal assignment. FEBS Lett. 338, 217-222.
46. Yu V. C. and Sadee W. (1988) Efficacy and tolerance of narcotic analgesics at the mu opioid receptor in differentiated human neuroblastoma cells. J. Pharmaocl. Exp. Ther. 245, 350-355.
47. Yu V. C., Richards M. L., and Sadee W. (1986) A human neuroblastoma cell line expresses μ and ε opioid receptor sites. J. Biol. Chem. 261, 1065-1070.
48. Yu V. C., Elger S., Duan D.-S., Lameh J., and Sadee W. (1990) Regulation of cyclic AMP by the μ-opioid receptor in human neurblastoma SH-SY5Y cells. J. Neurochem. 55, 1390-1396.